Back to DM DME Capital Management, LP

ROIVROIV
10 quarters

Position history for DMDME Capital Management, LP's holdings in ROIVANT SCIENCES LTD

DME Capital Management, LP holds 2.2M shares of ROIV (ROIVANT SCIENCES LTD), worth $76.2M as of 2026-Q2. ROIV represents 1.9% of DME Capital Management, LP's portfolio.

Current Value

$76.2M

Current Shares

2.2M

Total Value Change

+$32M

Total Shares Change

-2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
2.2M
0.0%
$76.2M1.9%$35.39
0
2026-Q1
Increased
2.2M
+4.0%
$59.6M1.9%$27.70
49
2025-Q4
Decreased
2.1M
-9.1%
$44.9M1.6%$21.70
0
2025-Q3
Decreased
2.3M
-50.0%
$34.4M1.4%$15.13
0
2025-Q2
Decreased
4.6M
-16.4%
$51.3M2.2%$11.27
0
2025-Q1
Increased
5.4M
+3.2%
$54.9M2.8%$10.09
53
2024-Q4
Decreased
5.3M
-0.7%
$62.4M3.2%$11.83
0
2024-Q3
Increased
5.3M
+10.3%
$61.3M2.5%$11.54
57
2024-Q2
Increased
4.8M
+14.8%
$50.9M2.5%$10.57
59
2024-Q1
First report
4.2M
-
$44.2M2.0%$10.54
0

Other major holders of ROIV: FMR LLC, BlackRock, Inc., MORGAN STANLEY

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used